Internal Medicine, Hematology & Oncology · Tulare, CA
NPI
1861478422
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1088 N Cherry St
Tulare, CA, 93274
Phone (559) 688-8899
Groups this clinician bills Medicare through
Medicare paid, 2024
$140K
11,606 services
Medicare patients, 2024
172
Average age 74
Drug cost, 2024
$2.5M
4,809 prescriptions
Company payments, 2025
$818
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Samuel S Kuo was code 99213 (office e&m - established), 661 times for 151 patients. In total Samuel S Kuo billed 11,606 services in 39 codes, and Medicare paid $140K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-04-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 661 | 151 | $65.25 | $43K |
| 99214 Office E&M - Established | Office | 311 | 131 | $92.27 | $29K |
| 96372 Injection Administration | Office | 47 | 17 | $11.06 | $520 |
| 90658 Vaccine Product | Office | 36 | 36 | $21.21 | $764 |
| G0008 Administration of influenza virus vaccine | Office | 36 | 36 | $32.91 | $1,185 |
| 99205 Office E&M - New | Office | 21 | 21 | $162.21 | $3,406 |
By year: 2022 $401K for 19,400 services; 2023 $310K for 20,634 services; 2024 $140K for 11,606 services.
Medicare prescription drug claims, 2024
In 2024, the drug Samuel S Kuo prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 343 prescriptions and refills. In total Samuel S Kuo wrote 4,809 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 343 | 343 | 40 | $6,534 |
| Atorvastatin Calcium Generic | 169 | 501 | 53 | $1,461 |
| Amlodipine Besylate Generic | 130 | 382 | 41 | $531 |
| Losartan Potassium Generic | 110 | 305 | 31 | $826 |
| Lisinopril Generic | 98 | 283 | 29 | $572 |
| Levothyroxine Sodium Generic | 97 | 280 | 26 | $800 |
| Gabapentin Generic | 95 | 169 | 31 | $1,384 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 94 | 94 | 22 | $58K |
| Furosemide Generic | 89 | 220 | 33 | $287 |
| Zolpidem Tartrate Generic | 88 | 99 | 14 | $464 |
| Amoxicillin Generic | 88 | 88 | 57 | $213 |
| Ibuprofen Generic | 86 | 100 | 25 | $694 |
| Metformin Hcl Generic | 74 | 214 | 20 | $420 |
| Mirtazapine Generic | 73 | 141 | 24 | $903 |
| Celecoxib Generic | 68 | 84 | 16 | $4,594 |
Brand drugs: 581 claims; generic drugs: 4,206 claims; opioid claims: 430.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Samuel S Kuo $818 ($818 in general payments such as food, travel and fees) from 18 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $178.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 6 | $178 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $86.61 |
| Janssen Biotech, Inc. JNJ | 2 | $64.62 |
| Shield Therapeutics Inc STX.L | 2 | $56.75 |
| Merck Sharp & Dohme LLC MRK | 2 | $55.18 |
| Aveo Pharmaceuticals, Inc. | 2 | $48.8 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $41.46 |
| Incyte Corporation INCY | 2 | $39.37 |
| Sobi, Inc SOBI.ST | 1 | $35.25 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $32.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.